jdm

Journal of Diabetes & Metabolism

ISSN - 2155-6156

Mini Review - (2023) Volume 14, Issue 7

Fatigue in Patients with Type II Diabetes Mellitus in Korea: Contributing Factors

Robert Reyes*
 
*Correspondence: Robert Reyes, Unidad de Endocrinologia, Hospital Universitario Torrecardenas, Almeria, Spain, Email:

Author info »

Abstract

Fatigue is a common symptom experienced by individuals with type II diabetes mellitus and can significantly impact their quality of life. This article explores the factors influencing fatigue in patients with type II diabetes mellitus in Korea, focusing on the unique cultural, lifestyle, and healthcare system factors that may contribute to fatigue in this population. Physical factors, such as glycemic control and obesity, play a role in fatigue experienced by individuals with diabetes. Psychosocial factors, including psychological distress and diabetes-related distress, can also contribute to fatigue. Lifestyle factors, such as physical inactivity and sleep disturbances, [1] further exacerbate fatigue in this population. Recognizing and addressing these factors are essential for healthcare professionals to provide comprehensive care and improve the well-being of patients with type II diabetes mellitus. Strategies aimed at optimizing glycemic control, promoting physical activity, addressing psychosocial well-being, and managing sleep disorders can help alleviate fatigue and improve overall health outcomes in individuals with type II diabetes mellitus in Korea [2].

Keywords

Fatigue; Hypoglycaemia; Type 2 diabetes mellitus

Introduction

Fatigue is a common and distressing symptom experienced by individuals with type II diabetes mellitus. Understanding the factors contributing to fatigue in this population is crucial for improving patient care and quality of life. This article focuses on exploring the factors influencing fatigue in patients with type II diabetes mellitus in Korea, shedding light on potential determinants and implications for healthcare professionals [3].

Prevalence and impact of fatigue in type II diabetes mellitus

Fatigue is a prevalent symptom among individuals with type II diabetes mellitus, affecting their daily functioning and overall well-being. It can have a profound impact on various aspects of life, including work productivity, social interactions, and adherence to diabetes management regimens. However, the specific factors influencing fatigue in this population may vary due to cultural, lifestyle, and healthcare system differences [4-6].

Physical factors

Glycemic control: Poor glycemic control, characterized by elevated blood glucose levels, has been associated with increased fatigue in individuals with type II diabetes mellitus. Fluctuating glucose levels and chronic hyperglycemia can contribute to fatigue by impairing energy metabolism and causing oxidative stress.

Obesity: Excess body weight and obesity are prevalent in individuals with type II diabetes mellitus and can contribute to fatigue. Adipose tissue dysfunction, insulin resistance, and hormonal imbalances associated with obesity may negatively affect energy levels and contribute to fatigue [7, 8].

Psychosocial factors

Psychological distress: Anxiety, depression, and stress are commonly experienced by individuals with type II diabetes mellitus and are known to be associated with fatigue. Psychosocial factors can influence fatigue through various mechanisms, including sleep disturbances, altered neuroendocrine function, and decreased motivation for self-care behaviors [9- 12].

Diabetes-related distress: The burden of diabetes management, such as medication adherence, dietary restrictions, and regular blood glucose monitoring, can lead to diabetes-related distress. The added emotional and psychological stress associated with diabetes management can contribute to fatigue [12].

Lifestyle factors

Physical inactivity: Sedentary behavior and lack of regular physical activity are prevalent in individuals with type II diabetes mellitus and can contribute to fatigue. Exercise has been shown to improve energy levels, reduce fatigue, and enhance overall well-being in this population.

Sleep disturbances: Sleep disorders, including obstructive sleep apnea and poor sleep quality, are common in individuals with type II diabetes mellitus and can exacerbate fatigue. Addressing and treating sleep disturbances may help alleviate fatigue symptoms [13- 15].

Conclusion

Fatigue is a significant concern for individuals with type II diabetes mellitus in Korea, impacting their daily lives and disease management. Multiple factors contribute to fatigue, including glycemic control, obesity, psychological distress, diabetes-related distress, physical inactivity, and sleep disturbances. Recognizing and addressing these factors are crucial for healthcare professionals in providing comprehensive care and improving the quality of life for patients with type II diabetes mellitus. Strategies such as optimizing glycemic control, promoting physical activity, addressing psychosocial wellbeing, and managing sleep disorders can help alleviate fatigue and enhance overall health outcomes in this population.

Acknowledgement

None

Conflict of Interest

None

References

  1. Sugawara A, Kawai K, Motohashi S (2012) HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Diabetologia 55: 2128-2131.
  2. Indexed at, Google Scholar, Crossref

  3. Luk AO, Ma RC, Lau ES (2013) Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 29: 384-390.
  4. Indexed at, Google Scholar, Crossref

  5. Penno G, Solini A, Bonora E (2013) Renal Insufficiency and Cardiovascular Events Study Group. HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Care 36: 2301-2310.
  6. Indexed at, Google Scholar, Crossref

  7. Chiu WC, Lai YR, Cheng BC, Huang CC, Chen JF (2020) HbA1C Variability Is Strongly Associated with Development of Macroalbuminuria in Normal or Microalbuminuria in Patients with Type 2 Diabetes Mellitus: A Six-Year Follow-Up Study. Biomed Res Int 25: 7462158.
  8. Indexed at, Google Scholar, Crossref

  9. Lee S, Liu T, Zhou J, Zhang Q, Wong WT (2021) Predictions of diabetes complications and mortality using HbA1c variability: a 10-year observational cohort study. Acta Diabetol 58: 171-180.
  10. Indexed at, Google Scholar, Crossref

  11. Allen AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, McCoy RG (2018) Healthcare cost and utilization in non-alcoholic fatty liver disease: real-world data from a large U.S. claims database. Hepatology (Baltimore, Md) 68: 2230-2238.
  12. Indexed at, Google Scholar, Crossref

  13. Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H (2015) Non-alcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol 110: 10-14.
  14. Indexed at, Google Scholar, Crossref

  15. Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, et al. (2019) Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. BMC Med 17: 95.
  16. Indexed at, Google Scholar, Crossref

  17. Ezaz G, Trivedi HD, Connelly MA, Filozof C, Howard K, et al. (2020) Differential associations of circulating microRNAs with pathogenic factors in NAFLD. Hepatol Commun 4: 670-680.
  18. Indexed at, Google Scholar, Crossref

  19. Association AD (2020) Improving care and promoting health in populations: standards of medical care in diabetes-2020. Diabetes Care 43: 7-13.
  20. Indexed at, Google Scholar, Crossref

  21. Watt GP, De La Cerda I, Pan JJ, Fallon MB, Beretta L, et al. (2020) Elevated glycated hemoglobin is associated with liver fibrosis, as assessed by elastography, in a population-based study of Mexican Americans. Hepatol Commun 4: 1793-1801.
  22. Indexed at, Google Scholar, Crossref

  23. Mäkimattila S, Harjutsalo V, Forsblom C, Groop PH (2020) FinnDiane Study Group. every fifth individual with type 1 diabetes suffers from an additional autoimmune disease: a Finnish nationwide study. Diabetes Care 43: 1041-1047.
  24. Indexed at, Google Scholar, Crossref

  25. Adamsson Eryd S, Svensson AM, Franzén S, Eliasson B, Nilsson PM (2017) Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up. Diabet Med 34: 411-418.
  26. Indexed at, Google Scholar, Crossref

  27. Bjerg L, Hulman A, Carstensen B, Charles M, Witte DR (2019) Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study. Diabetologia 62: 633-643.
  28. Indexed at, Google Scholar, Crossref

  29. Głowinska-Olszewska B, Borysewicz-Sańczyk H, Sawicka B, Klonowska B, Charemska D, et al. (2020) Does Hashimoto's thyroiditis increase the risk of cardiovascular disease in young Type 1 diabetic patients? Front Endocrinol (Lausanne) 11: 431.
  30. Indexed at, Google Scholar, Crossref

Author Info

Robert Reyes*
 
Unidad de Endocrinologia, Hospital Universitario Torrecardenas, Almeria, Spain
 

Citation: Robert Reyes. Fatigue in Patients with Type II Diabetes Mellitus in Korea: Contributing Factors. J Diabetes Metab, 2023, 14(7): 1021.

Received: 30-Jun-2023, Manuscript No. jdm-23-25887; Editor assigned: 03-Jul-2023, Pre QC No. jdm-23-25887(PQ); Reviewed: 17-Jul-2023 Revised: 24-Jul-2023, Manuscript No. jdm-23-25887(R); Published: 31-Jul-2023, DOI: 10.35248/2155-6156.10001021

Copyright: © 2023 Reyes R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.